ArticleCancers2022

Inhibiting Endothelin Receptors with Macitentan Strengthens the Bone Protective Action of RANKL Inhibition and Reduces Metastatic Dissemination in Osteosarcoma.

Javier Muñoz-Garcia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.